Heart Failure Treatments Such As Angiotensin Receptor/Neprilysin Inhibitor Improve Heart Failure Status and Glucose Metabolism

A recent study suggested that angiotensin receptor/neprilysin inhibitor (ARNI; sacubitril/valsartan) can improve functional capacity and cardiac reverse remodeling in patients with heart failure with reduced ejection fraction (HFrEF). Another study suggested that ARNI reduced glycated hemoglobin (Hb...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashiwagi, Yusuke, Nagoshi, Tomohisa, Ogawa, Kazuo, Kawai, Makoto, Yoshimura, Michihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971101/
https://www.ncbi.nlm.nih.gov/pubmed/35371876
http://dx.doi.org/10.7759/cureus.22762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971101/
https://www.ncbi.nlm.nih.gov/pubmed/35371876
http://dx.doi.org/10.7759/cureus.22762

Ejemplares similares